Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Dow

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Clindamycin Phosphate And Benzoyl Peroxide, and when can generic versions of Clindamycin Phosphate And Benzoyl Peroxide launch?

Clindamycin Phosphate And Benzoyl Peroxide is a drug marketed by Actavis Labs Ut Inc, Glenmark Pharms, Mylan Pharms Inc, Perrigo Israel, Perrigo Uk Finco, Taro, Taro Pharms, Tolmar, and Zydus Pharms. and is included in fourteen NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is benzoyl peroxide; clindamycin phosphate. There are seventeen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.

Summary for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Drug patent expirations by year for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Valeant Pharmaceuticals International, Inc.Phase 2
Icahn School of Medicine at Mount SinaiPhase 2
Cadila Healthcare LimitedPhase 3

See all CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE clinical trials

Pharmacology for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Synonyms for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Benzoyl peroxide mixture with Clindamycin phosphate
Benzoyl peroxide, clindamycin drug combination
Clindamycin mixt. with benzoyl peroxide
Clindoxyl gel
DUAC gel
L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), mixt. with dibenzoyl peroxide
Onexton
SCHEMBL15568161

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 205128-001 Jun 19, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Taro CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 206575-001 Aug 19, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo Israel CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 205397-001 Sep 9, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Tolmar CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 204087-001 Jun 27, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Taro CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 208683-001 Jun 5, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 210794-001 Dec 28, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 209252-001 Mar 14, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
Express Scripts
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.